Literature DB >> 16207970

Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections.

C J McIver1, C F H Jacques, S S W Chow, S C Munro, G M Scott, J A Roberts, M E Craig, W D Rawlinson.   

Abstract

Potential causes of congenital infection include Toxoplasma gondii and viruses such as cytomegalovirus (CMV), enterovirus, hepatitis C virus, herpes simplex virus types 1 and 2 (HSV-1 and -2), human herpesvirus types 6, 7, and 8, lymphocytic choriomeningitis virus, parvovirus, rubella virus, and varicella-zoster virus. Testing for each of these agents using nucleic acid tests is time consuming and the availability of clinical samples such as amniotic fluid or neonatal blood is often limited. The aim of this study was to develop multiplex PCRs (mPCRs) for detection of DNA and RNA agents in the investigation of congenital infection and an mPCR for the viruses most commonly requested in a diagnostic virology laboratory (CMV, Epstein-Barr virus, enterovirus, HSV-1, HSV-2, and varicella-zoster virus). The assays were assessed using known pathogen-positive tissues (cultures, placentae, plasma, and amniotic fluid) and limits of detection were determined for all the agents studied using serial dilutions of plasmid targets. Nested PCR was performed as the most sensitive assay currently available, and detection of the amplicons using hybridization to labeled probes and enzyme-linked immunosorbent assay detection was incorporated into three of the four assays. This allowed detection of 10 to 10(2) copies of each agent in the samples processed. In several patients, an unexpected infection was diagnosed, including a case of encephalitis where HSV was the initial clinical suspicion but CMV was detected. In the majority of these cases the alternative agent could be confirmed using reference culture, serology, or fluorescence methods and was of relevance to clinical care of the patient. The methods described here provide useful techniques for diagnosing congenital infections and a paradigm for assessment of new multiplex PCRs for use in the diagnostic laboratory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207970      PMCID: PMC1248455          DOI: 10.1128/JCM.43.10.5102-5110.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

Review 1.  Multiplex PCR: optimization and application in diagnostic virology.

Authors:  E M Elnifro; A M Ashshi; R J Cooper; P E Klapper
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  LightCycler multiplex PCR for the laboratory diagnosis of common viral infections of the central nervous system.

Authors:  S J Read; J L Mitchell; C G Fink
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.

Authors:  G Halwachs-Baumann; M Wilders-Truschnig; G Enzinger; M Eibl; W Linkesch; H J Dornbusch; B I Santner; E Marth; H H Kessler
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

Review 4.  Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery.

Authors:  L L Barton; M B Mets
Journal:  Clin Infect Dis       Date:  2001-07-05       Impact factor: 9.079

5.  Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens.

Authors:  L Liolios; A Jenney; D Spelman; T Kotsimbos; M Catton; S Wesselingh
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

6.  Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis.

Authors:  S Romand; M Wallon; J Franck; P Thulliez; F Peyron; H Dumon
Journal:  Obstet Gynecol       Date:  2001-02       Impact factor: 7.661

7.  Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases.

Authors:  A Meerbach; B Gruhn; R Egerer; U Reischl; F Zintl; P Wutzler
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

8.  Severe neonatal toxoplasmosis after third trimester maternal infection.

Authors:  Lawrence Armstrong; David Isaacs; Nick Evans
Journal:  Pediatr Infect Dis J       Date:  2004-10       Impact factor: 2.129

9.  Prenatal diagnosis of symptomatic congenital cytomegalovirus infection.

Authors:  B Guerra; T Lazzarotto; S Quarta; M Lanari; L Bovicelli; A Nicolosi; M P Landini
Journal:  Am J Obstet Gynecol       Date:  2000-08       Impact factor: 8.661

10.  Simplified hepatitis C virus genotyping by heteroduplex mobility analysis.

Authors:  P A White; X Zhai; I Carter; Y Zhao; W D Rawlinson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

View more
  14 in total

1.  Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research.

Authors:  Gai L McMichael; Amanda R Highet; Catherine S Gibson; Paul N Goldwater; Michael E O'Callaghan; Emily R Alvino; Alastair H MacLennan
Journal:  J Biomol Tech       Date:  2011-04

2.  Development and padronization of three multiplex PCRs for the diagnosis of Chlamydia trachomatis, Toxoplasma gondii, herpes simplex viruses 1 and 2, and Cytomegalovirus.

Authors:  Danielle A G Zauli; Carla Lisandre Paula de Menezes; Cristiane Lommez de Oliveira
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

Review 3.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies.

Authors:  L C Stene; M Rewers
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 4.  The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.

Authors:  A Louise McCormick; Edward S Mocarski
Journal:  Cell Mol Immunol       Date:  2014-12-29       Impact factor: 11.530

5.  Molecular Mechanisms behind Persistent Presence of Parvovirus B19 in Human Dilated Myocardium.

Authors:  Daiva Bironaitė; Ieva Kažukauskienė; Julius Bogomolovas; Dainius Daunoravičius; Artūras Jakubauskas; Dalius Vitkus; Edvardas Žurauskas; Kęstutis Ručinskas; Siegfried Labeit; Virginija Grabauskiene
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active australian women.

Authors:  Christopher J McIver; Nikolas Rismanto; Catherine Smith; Zin Wai Naing; Ben Rayner; M Josephine Lusk; Pamela Konecny; Peter A White; William D Rawlinson
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

7.  Next generation sequencing of human enterovirus strains from an outbreak of enterovirus A71 shows applicability to outbreak investigations.

Authors:  Sacha Stelzer-Braid; Matthew Wynn; Richard Chatoor; Matthew Scotch; Vidiya Ramachandran; Hooi-Ling Teoh; Michelle A Farrar; Hugo Sampaio; Peter Ian Andrews; Maria E Craig; C Raina MacIntyre; Hemalatha Varadhan; Alison Kesson; Philip N Britton; James Newcombe; William D Rawlinson
Journal:  J Clin Virol       Date:  2019-11-17       Impact factor: 3.168

Review 8.  Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and prevention.

Authors:  Wendy J van Zuylen; Stuart T Hamilton; Zin Naing; Beverly Hall; Antonia Shand; William D Rawlinson
Journal:  Obstet Med       Date:  2014-09-25

9.  Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile.

Authors:  Wing-Chi G Yeung; Ammira Al-Shabeeb; Chi Nam Ignatius Pang; Marc R Wilkins; Jacki Catteau; Neville J Howard; William D Rawlinson; Maria E Craig
Journal:  Diabetes       Date:  2012-04-03       Impact factor: 9.461

10.  Detection of human herpesvirus 8 by quantitative polymerase chain reaction: development and standardisation of methods.

Authors:  David J Speicher; Newell W Johnson
Journal:  BMC Infect Dis       Date:  2012-09-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.